Ah, the stock market. A bastion of rational thought, meticulous planning, and calm, measured reactions. Or, at least, that’s what the textbooks say. Then came the era of Donald J. Trump, where market movements often felt less like economic indicators and more like a particularly volatile reality television show. From the grand pronouncements of “Golden Fleets” to the dizzying dance of tariffs, 2025 proved once again that under Trump, the only constant is, well, change – and a healthy dose of market whiplash.
Indeed, the year 2025 has been a rollercoaster, with the S&P 500 (^GSPC) managing an impressive 18% return year-to-date, despite a backdrop of economic uncertainty largely fueled by the former (and potentially future) president’s trade policies. One might even call it resilient, or perhaps just incredibly confused. Either way, investors have certainly earned their keep.
The Art of the Tariff: A Masterclass in Market Mayhem
Let’s cast our minds back to April 2025, a month etched into the annals of market history as “Liberation Day.” Not for any actual liberation, mind you, but for the liberation of trillions of dollars from global stock markets. President Trump’s sweeping “Liberation Day” tariffs, unveiled with characteristic fanfare, sent shockwaves across the financial world, causing the S&P 500 to plummet below 5,000 points for the first time in nearly a year. On April 3, the Dow Jones Industrial Average (^DJI) shed a staggering 4%, or nearly 1,700 points, while the S&P 500 dropped 4.8% and the tech-heavy Nasdaq Composite (^IXIC) tumbled a dramatic 6%. These were the worst single-day performances for these indices since the dark days of the early COVID pandemic in 2020. Just for good measure, the very next day saw the S&P 500 drop another 6% as China’s inevitable retaliation raised fears of a full-blown trade war.
The sentiment was clear: markets dislike uncertainty, a rather understated observation from Morgan Stanley Wealth Management strategist Daniel Skelly. Yet, amidst the chaos, a peculiar pattern emerged. While the S&P 500 initially plunged a hefty 17% year-to-date due to these tariff announcements, it then staged a remarkable comeback, enjoying seven consecutive months of gains to finish with a 15% year-to-date return. It seems investors, much like a seasoned poker player, learned to read the bluffs and the eventual (and often temporary) climbdowns. The effective U.S. tariff rate, a metric that truly captures the impact on consumers, peaked at nearly 17% in April 2025, a sevenfold increase from January’s average. The Tax Foundation, ever the bearer of inconvenient truths, estimated these tariffs amounted to an average tax increase of $1,100 per U.S. household in 2025. A small price to pay for… well, whatever it was we were getting.
Then came the more granular strikes. In March 2025, the 25% tariffs on Canadian and Mexican imports, alongside an additional 10% on Chinese goods, officially took effect. The market’s reaction was swift and predictable: on March 4, the S&P 500 fell 1.2%, the Dow declined 1.6% (shedding 670 points), and the Nasdaq dipped 0.4%, all hitting 2025 lows. Analysts at Morgan Stanley sagely noted that sectors with high foreign revenue exposure, such as technology, materials, and energy, were particularly vulnerable, while defensive sectors like healthcare and utilities might just weather the storm. Goldman Sachs, ever the optimists, estimated that these trade policy changes would subtract a mere 0.4% from global GDP in 2025, though they conceded a 10% across-the-board tariff could multiply that impact by two or three. Such precision in predicting chaos is truly admirable.
Pharmaceutical Follies: A Prescription for… More Tariffs?
Not content with merely taxing everything else, September 2025 brought the promise of 100% import taxes on branded or patented pharmaceuticals, effective October 1. The catch? Companies building U.S. manufacturing plants would be exempt. This announcement, delivered with the usual flair, saw shares of major drugmakers like Merck & Co. Inc. (MRK), Eli Lilly and Co. (LLY), and Johnson & Johnson (JNJ) rise less than 1% in midday trading on September 26, slightly outperforming the broader S&P 500. Analysts, having apparently grown accustomed to this particular brand of policy, were largely unconcerned. Jefferies analyst Akash Tewari and BMO Capital Markets both suggested the impact on big drugmakers would be “not material” due to existing U.S. manufacturing plans and generous carve-outs. One might wonder if the pharmaceutical industry had a crystal ball, or perhaps just a very good lobbying team.
Battleships and Bombs: Geopolitical Grandstanding and the Market’s Shrug
Beyond the realm of trade, Trump’s pronouncements often veered into the geopolitical. December 2025 saw the announcement of a new class of Navy battleships, part of his “Golden Fleet” initiative. Despite a “century of evidence proving large warships are…” well, you get the idea, the market reacted with a surprising lack of skepticism. Defense contractors, ever the beneficiaries of such grand visions, saw their stocks surge. Huntington Ingalls Industries (HII) shares, for instance, tacked on 5% on December 22, 2025, following the announcement, and climbed nearly 2% to a fresh record high of $360.20 on December 23. The stock had already nearly doubled in value in 2025, a testament to the enduring appeal of government contracts. Even South Korean shipbuilder Hanwha Ocean (042660.KS), which owns the Philly Shipyard, saw its shares rocket as much as 14% (closing about 12% higher on December 23, 2025) in Seoul, as it was tasked with helping construct these “Trump-class battleships”. The broader defense sector, it seems, had a truly golden year, with HII alone adding 87.1% since the start of 2025. Who needs evidence when you have a “Golden Fleet”?
Then there were the strikes in Nigeria. On December 27, 2025, Trump announced U.S. strikes against ISIS targets in Nigeria. The market’s reaction? “Muted in thin holiday trading” for oil. However, earlier in November 2025, prior threats of military action against Nigeria by Trump had a more tangible impact. Nigeria’s financial markets reeled, with the Nigerian Exchange (NGX) All-Share Index dropping 0.25%, wiping out approximately ₦247 billion (about $170 million at ₦1442.80/$) in value on November 4, 2025. The naira also depreciated by 1.03% to ₦1,436.34/$. It seems some markets are more sensitive to presidential tweets than others.
Truth, Social, and the Market’s Reality Check
No discussion of Trump’s market impact would be complete without a nod to his social media venture. Digital World Acquisition Corp. (DWAC), the SPAC that merged with Trump Media & Technology Group (TMTG) in March 2024 (now trading as DJT), has been a spectacle in itself. As of December 26, 2025, DWAC (now DJT) boasted a market cap of $3.96 billion. Its 52-week high stood at $43.46, with a 52-week low of $10.18, a testament to its inherent volatility. Predictions for DWAC (now DJT) in 2025 were as varied as Trump’s policy positions, with some forecasting an average price around $60.53 for August 2025 and a potential high of $100.33. Others offered a more conservative outlook, with January 2025 predictions ranging from $29.78 to $81.27. The stock’s performance, much like a Trump rally, remains highly influenced by political events, regulatory scrutiny, and the ever-shifting sands of market sentiment around Truth Social’s operations. It’s a stock for those who enjoy a good gamble, or perhaps just a good story.
The Geopolitical Rollercoaster: Ukraine and the Price of Peace
Even the delicate dance of international diplomacy found itself on the market stage. Trump’s push for a peace agreement in the Russia-Ukraine war in February 2025, for instance, had a rather predictable impact on energy markets. Brent crude oil dipped approximately 2%, and European natural gas prices fell around 10% on the prospect of reduced risk premiums and a potential return of Russian gas supply. European equity indices, ever the pragmatists, generally rose, while Russian and Ukrainian assets, perhaps fueled by a glimmer of hope, rallied more significantly.
However, the path to peace is rarely smooth. In August 2025, following a meeting between Trump and Ukrainian President Volodymyr Zelenskyy, where Trump pledged U.S. support for Ukraine’s security in any war-ending agreement, market sentiment initially improved. Yet, the aerospace and defense sector, having enjoyed a robust year, saw a 2.8% decline on August 19, its largest single-day drop since early April, as investors, perhaps wisely, decided to lock in profits. Fast forward to November 2025, and Russian equities rallied strongly, with the MOEX Russia Index rising 2.4% at the opening bell on November 21, as a Trump-backed peace plan was once again discussed. It seems even the prospect of peace, however fleeting, can move markets, particularly those directly involved in the conflict.
Conclusion: The Enduring Trump Effect
In the grand tapestry of 2025, Donald Trump’s impact on stock markets remained a fascinating blend of bombast, policy flip-flops, and market resilience. From the initial shockwaves of “Liberation Day” tariffs that sent indices tumbling, to the subsequent rebounds fueled by a combination of policy adjustments and underlying economic strength, investors have been on a wild ride. The defense sector thrived on promises of a “Golden Fleet,” while pharmaceutical giants largely shrugged off new tariffs, having already anticipated the regulatory winds. Even geopolitical interventions, from Nigeria to Ukraine, elicited distinct, if sometimes fleeting, market reactions.
Ultimately, the Trump market of 2025 proved that while rhetoric can certainly create volatility, the underlying currents of corporate earnings, investor sentiment, and global economic realities often dictate the long game. It’s a market that demands a strong stomach, a keen eye for the absurd, and perhaps, a slightly sarcastic sense of humor. Because when it comes to predicting the next move, one can only observe, react, and perhaps, chuckle quietly to oneself.
DISCLAIMER: We read Trump’s posts so you don’t have to. This is comedy meets market data, not financial advice. Not political advice either – we just like charts and chaos.
Elana Harper is a seasoned financial editor and market analyst with over a decade of experience covering global equities, economic trends, and corporate earnings. Known for her sharp insights, Elana specializes in making complex financial topics accessible to a broad audience. She now serves as the Senior Financial Editor at Stock Market Watch, where she oversees daily market coverage and political commentary.